Description

1-[1-[2-(3,4-Dimethoxyphenyl)-2-Hydroxy-1-Methylethyl]-4-Piperidinyl]-1,3-Dihydro-2H-Benzimidazole-2-One/Butanedioic Acid,(1:X) is a high-purity pharmaceutical intermediate and research chemical with the CAS number 85984-40-3. This compound is critical for the development and synthesis of advanced active pharmaceutical ingredients (APIs), offering a key building block for medicinal chemistry research. It is primarily utilized by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic institutions engaged in drug discovery programs.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex drug molecules, particularly in central nervous system (CNS) and cardiovascular research.
• Active Pharmaceutical Ingredient (API) Development: Serves as a core structural component for developing new therapeutic agents.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes.
• Biochemical Research: Employed as a tool compound for studying specific biological pathways and receptor interactions.
• Fine Chemical Synthesis: Utilized in multi-step organic synthesis for creating specialized, high-value chemical entities.
• Reference Standard: Serves as an analytical standard for quality control and method development in pharmaceutical analysis.

Basic Information

Product Name	1-[1-[2-(3,4-Dimethoxyphenyl)-2-Hydroxy-1-Methylethyl]-4-Piperidinyl]-1,3-Dihydro-2H-Benzimidazole-2-One/Butanedioic Acid,(1:X)
CAS No.	85984-40-3
Molecular Formula	C23H27N3O4 • x(C4H6O4)
Molecular Weight	Contact for details
Synonyms	1-[1-[2-(3,4-Dimethoxyphenyl)-2-hydroxy-1-methylethyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one succinate; Benzimidazol-2-one derivative with succinic acid; CAS 85984-40-3; 1-(1-(2-(3,4-Dimethoxyphenyl)-2-hydroxypropyl)piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one succinate; Succinic acid compound with 1-[1-[2-(3,4-dimethoxyphenyl)-2-hydroxy-1-methylethyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one (1:1)
EINECS	Contact for details

Quality Control

Our production of 1-[1-[2-(3,4-Dimethoxyphenyl)-2-Hydroxy-1-Methylethyl]-4-Piperidinyl]-1,3-Dihydro-2H-Benzimidazole-2-One/Butanedioic Acid,(1:X) adheres to stringent quality management systems, ensuring batch-to-batch consistency and high purity suitable for pharmaceutical research. All products undergo rigorous analytical testing, including HPLC, NMR, and MS, to confirm identity and purity. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each batch to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and light-sensitive; containers must be kept tightly sealed to minimize exposure to atmospheric moisture and light to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.